Weekly Tech+Bio Highlights #59: AI-Designed Cancer Drug Shows Early Responses

DeepMind & Yale release a 27B single-cell foundation model, an up to $1B protein design deal with Takeda, and Thermo Fisher adds OpenAI’s tools across its R&D stack

and

Oct 20, 2025

∙ Paid

Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.

If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button:

Where Tech Meets Bio

Weekly Tech+Bio Highlights #59: AI-Designed Cancer Drug Shows Early Responses

DeepMind & Yale release a 27B single-cell foundation model, an up to $1B protein design deal with Takeda, and Thermo Fisher adds OpenAI’s tools across its R&D stack

This post is for paid subscribers